MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $571,072 | -24.8% | 183,036 | +10.7% | 0.00% | – |
Q2 2023 | $759,035 | +13.4% | 165,367 | +22.3% | 0.00% | – |
Q1 2023 | $669,339 | -0.3% | 135,220 | +10.0% | 0.00% | – |
Q4 2022 | $671,253 | -77.5% | 122,940 | -73.2% | 0.00% | -100.0% |
Q3 2022 | $2,980,000 | -51.3% | 458,420 | -64.5% | 0.00% | 0.0% |
Q2 2022 | $6,113,000 | -12.9% | 1,292,242 | +28.7% | 0.00% | 0.0% |
Q1 2022 | $7,016,000 | +186.5% | 1,003,738 | +317.5% | 0.00% | – |
Q4 2021 | $2,449,000 | +28.3% | 240,394 | +53.7% | 0.00% | – |
Q3 2021 | $1,909,000 | – | 156,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |